Status:
COMPLETED
A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Conditions:
Hypertension
Eligibility:
All Genders
19+ years
Phase:
PHASE4
Brief Summary
Phase 4 clinical trial to Evaluate the blood pressure lowering effect of a Candesartan/Hydrochlorothiazide(Candemore Plus Tab) versus Candesartan/Amlodipine(Cantabell Tab) in Hypertensive Patients
Eligibility Criteria
Inclusion
- over 19 years old
- Agreement with written informed consent
- Hypertensive Patients
Exclusion
- Patients with secondary hypertension
- Participated in other trial within 30 days
- In investigator's judgement
Key Trial Info
Start Date :
September 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 3 2020
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT04521023
Start Date
September 20 2017
End Date
June 3 2020
Last Update
August 20 2020
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Ajou University Hospital
Suwon, Gyeonggi-do, South Korea
2
Hallym Univ. Medical Center
Anyang, South Korea
3
Daegu Catholic Univ. Medical Center
Daegu, South Korea
4
MYONGJI Hospital
Goyang-si, South Korea